Abionyx Pharma announces new strategy, promising preclinical results
LAKELAND–Abionyx Pharma, a startup biotech company with operations in Michigan and France, announced its strategy in ophthalmology and new positive preclinical results in two technological platforms: apotherapy and biovectorisation. Cyrille …